Facebook
Twitter
LinkedIn
ForwardMiami Brain Symposium, Seventh Annual
Learning Objectives
Upon completion of this symposium, participants should be better able to:
- Examine the role of novel bench-to-bedside investigations for treating glioblastoma by targeted androgen receptors and exploring glutaminase inhibitors.
- Recognize the advantages of implementing tumor treating fields for patients with brain metastases.
- Evaluate novel systemic therapeutics for gliomas with preclinical and early clinical data, such as CAR T-cell therapies and other vaccine options.
- Understand the role of systemic therapies and craniospinal irradiation in treating leptomeningeal disease.
- Recognize the roles of surveillance, surgery, and stereotactic radiosurgery for patients with benign tumors, such as vestibular schwannomas and meningiomas.
Who Should Attend
Adult and pediatric neurologists, adult and pediatric medical oncologists, neurosurgeons, neuro-oncologists, neuroradiologists, diagnostic radiologists, radiation oncologists, emergency medicine physicians, pathologists, neuroscience nurses, neurosurgery nurses, nurse practitioners, occupational therapists, respiratory therapists, physical therapists, clinical pharmacists, clinical laboratory personnel, rehabilitation and pain management specialists and physician assistants, as well as other specialists interested in the fields of neuro-oncology and neuroscience.
This course will add tremendous value to residents in training as well as fellows in multiple specialties, including family practice, internal medicine, pediatrics, neurology, neurosurgery, medical oncology, radiation oncology, radiology, and pathology.
Registration and Fees
| Before Monday, September 23, 2024 | After Monday, September 23, 2024 | |
| Physicians* | $245 | $295 |
| Baptist Health Employees | $45 | $55 |
| Physicians-in-Training** | $75 | $95 |
| Others | $75 | $95 |
* Group discounts available for three or more physicians who register together as a group by Friday, November 15. No add-ons. Call for details.
** Registration must be accompanied by a letter from the Fellowship/Residency Director.
Event date: Friday, December 13, 2024 | 7:55 a.m. – 4:30 p.m.
Cancellation Policy
Cancellations must be received by Friday, November 29, 2024 to receive a refund of the registration fee, less a $35 administrative fee. Registration fees are not refundable after Friday, November 29, 2024.
Agenda
| 7:30 a.m. - 7:50 a.m. | Breakfast & Visit Exhibits |
| 7:55 a.m. - 8:00 a.m. | Welcome and Introductions Rupesh Kotecha |
| Glioblastoma Therapy Advances from Bench to Clinic Moderator: Yazmin Odia | |
| 8:00 a.m. - 8:25 a.m. | This House Believes There Is No Role for Dose-Escalation for Glioblastoma Michelle Kim |
| 8:25 a.m. - 8:50 a.m. | Targeting Androgen Receptors in Glioblastoma Chi (Kevin) Zhang |
| 8:50 a.m. - 9:15 a.m. | Exploring Glutaminase Inhibition in Glioma Sani H. Kizilbash |
| 9:15 a.m. - 9:40 a.m. | Vaccines Therapy for Glioblastomas Manmeet Ahluwahlia |
| 9:40 a.m. - 9:55 a.m. | Questions and Answers |
| 9:55 a.m. - 10:10 a.m. | Break and Visit Exhibits |
| Advances in the Management of Other Brain Tumors Moderator: Rupesh Kotecha | |
| 10:10 a.m. - 10:50 a.m. | Surveillance vs. SRS for Asymptomatic Vestibular Schwannomas Pablo Recinos Paul Brown |
| 10:50 a.m. - 11:15 a.m. | Surgical Advances for Skull Base Tumors Christina Jackson |
| 11:15 a.m. - 11:40 a.m. | Radiotherapy Advances for Skull Base Tumors Joshua D. Palmer |
| 11:40 a.m. - 12:05 p.m. | Novel Systemic Therapies for Recurrent Meningiomas Yazmin Odia |
| 12:05 p.m. - 12:10 p.m. | Questions and Answers |
| 12:10 p.m. - 12:20 p.m. | Visit Exhibits |
| 12:20 p.m. - 1:00 p.m. | Product Theater |
| 1:00 p.m. - 1:10 p.m. | Lunch and Visit Exhibits |
| The Great Debates Moderator: Minesh Mehta | |
| 1:10 p.m. - 1:50 p.m. | Systemic Therapy vs. Craniospinal Irradiation for Leptomeningeal Disease Adriene Bore Jonathan Yang |
| 1:50 p.m. - 2:30 p.m. | SRS vs. WBRT for Multiple (>10) Brain Metastases Paul Brown Rupesh Kotecha |
| 2:10 p.m. - 2:30 p.m. | Break and Visit Exhibits |
| Innovations Moderator: Manmeet Ahluwahlia | |
| 2:30 p.m. - 2:55 p.m. | Novocure METIS Minesh Mehta |
| 2:55 p.m. - 3:20 p.m. | Pediatric Brain Tumor John T. Lucas, Jr. |
| 3:20 p.m. - 3:45 p.m. | Development Considerations for CAR T Cell Therapy for GBM Steven Bagley |
| 3:45 p.m. - 3:55 p.m. | Questions and Answers |
| 3:55 p.m. - 4:00 p.m. | Closing Remarks and Adjourn Yazmin Odia |
NOTE: Schedule subject to change.
About the Venue
Next to Baptist Hospital, Hilton Miami is two miles from Dadeland Mall and 10 minutes from Dadeland South Metro Station. Miami International Airport is 13 miles away. Hilton Miami offers a wellness center with yoga and Pilates classes plus massages, a heated pool, and guest rooms with fitness equipment. Hilton Miami Dadeland has met cleanliness standards for a WELL Health-Safety Rating.
⚠ | COVID-19 Protocols Notice for All Attendees, Exhibitors and VendorsSelf-screening is required for all in-person attendees. If you have any symptoms of respiratory illness, you must refrain from attending in person. Please be sure to read our COVID Protocols for all in-person education prior to registering for this activity. |
Symposium Directors
Deputy Director
Chief, Scientific Officer
Chief, Solid Tumor Medical Oncology
Baptist Health Miami Cancer Institute
Member, Memorial Sloan Kettering Cancer Alliance
Miami, Florida
Chief, Radiosurgery
Director, CNS Metastasis Program
Director of Research, Radiation Oncology
Baptist Health Miami Cancer Institute
Member, Memorial Sloan Kettering Cancer Alliance
Professor, Department of Radiation Oncology
FIU Herbert Wertheim College of Medicine
Miami, Florida
Chair, Division of Neurosurgery
Chief Medical Executive
Baptist Health Miami Neuroscience Institute
Irma & Kalman Bass Endowed Chair in Clinical Neuroscience
Miami, Florida
Deputy Director and Chief of Radiation Oncology
Baptist Health Miami Cancer Institute
Member, Memorial Sloan Kettering Cancer Alliance
Miami, Florida
Chief, Neuro-Oncology
Baptist Health Miami Cancer Institute
Member, Memorial Sloan Kettering Cancer Alliance
Miami, Florida
Faculty
Hematology-Oncology
Assistant Professor of Medicine
Perelman School of Medicine
University of Pennsylvania
Philadelphia, Pennsylvania
Neurologist and Neuro-Oncologist
Memorial Sloan Kettering Cancer Center
New York, New York
Wilmeth Professor of Radiation Oncology
Co-Section Chief, CNS Pediatrics
Mayo Clinic
Rochester, Minnesota
Neurosurgeon
University of Pennsylvania
Philadelphia, Pennsylvania
Director, Medical Student Education
Professor, Radiation Oncology
University of Michigan Medical School
Ann Arbor, Michigan
Neuro-Oncologist
Mayo Clinic
Rochester, Minnesota
Radiation Oncologist
St. Jude Children’s Research Hospital
Memphis, Tennessee
Associate Professor
Director of CNS
Pediatric Radiation Oncology
Department of Radiation Oncology
The James Cancer Center
The Ohio State University
Columbus, Ohio
Neurosurgeon
Cleveland Clinic
Cleveland, Ohio
Radiation Oncologist
NYU Langone Health
New York, New York
Radiation Oncologist
University of Nebraska Medical Center
Nebraska Medicine
Omaha, Nebraska
Disclosures And Resolution Of Conflict Of Interest Disclosure Policy and Disclaimer
Accreditation
Baptist Health South Florida is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. Baptist Health has been re-surveyed by the ACCME and awarded Commendation for 6 years as a provider of CME for physicians.
Baptist Health South Florida designates this live activity for a maximum of 6.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This activity has been approved for 6.5 credit hours, CE Broker Course #20-1237164, by the Florida Boards of Medicine, Osteopathic Medicine, Psychology and by the Florida Council of Physician Assistants.
This activity has also been approved for 6.5 credits for Nurse Practitioners, Nurses, Laboratory Personnel, Occupational Therapists, Respiratory Therapists . Baptist Health South Florida CE Broker Provider #50-182.
The American Academy of Nurse Practitioners Certification Board (AANPCB) accepts CEs accredited by the ACCME. Individuals are responsible for checking with the AANPCB for further guidelines.
AMA PRA Category 1 Credits™ claimed by physicians attending live events certified and organized in the United States for AMA PRA Category 1 Credits™ can be claimed through the agreement on mutual recognition of credits between UEMS and AMA, considered as being equal to the European Continuous Medical Education Credits (ECMEC©) granted by the UEMS. One AMA PRA Category 1 Credit™ is equivalent to one (1) hour of European EACCME Credit (ECMEC©). Each medical specialist should claim only those hours of credit that he/she actually spent in the educational activity.
Disclaimer
Baptist Health South Florida presents this CME activity for use by healthcare professionals for educational purposes only. Opinions, perspectives and information presented by the faculty represent their ideas and views, and participants should carefully consider all available scientific data before acting on knowledge gained through this activity. Additionally, participants should consult the US Food and Drug Administration (FDA) for approved uses prior to prescribing medications or utilizing medical devices discussed in this activity.
While Baptist Health makes reasonable efforts to ensure that accurate information is presented, no warranty, expressed or implied, is offered. Participants should rely on their own clinical judgment, knowledge and experience before applying information acquired to their professional use.
Available Credit
- 6.50 AMA PRA Category 1 Credit™
- 6.50 General certificate of attendance
- 6.50 Florida Board of Laboratory Personnel
- 6.50 Nurse Practitioners
- 6.50 Florida Board of Nursing
- 6.50 Florida Board of Occupational Therapy
- 6.50 Florida Board of Respiratory Therapy